TipRanks
Go Ultimate55% OFF

Compare TSURUHA Holdings (TSUSF) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
TSUSFTSURUHA Holdings$14.12$6.39B17.51-18.14%Moderate BuyUnlock the TSUSF analyst price target with TipRanks PremiumTSUSFUnlock the TSUSF top-analyst price target with TipRanks Premium
JP:9989Sundrug CoJPY 3,616.00JPY 422.80B13.44-13.74%Moderate BuyUnlock the JP:9989 analyst price target with TipRanks PremiumTSUSF vs JP:9989Unlock the JP:9989 top-analyst price target with TipRanks Premium
JP:7649Sugi Holdings CoJPY 1,304.50JPY 506.97B16.12-21.34%Moderate BuyUnlock the JP:7649 analyst price target with TipRanks PremiumTSUSF vs JP:7649Unlock the JP:7649 top-analyst price target with TipRanks Premium
JP:3148Create SD Holdings Co., Ltd.JPY 3,170.00JPY 200.40B12.200.16%―Unlock the JP:3148 analyst price target with TipRanks PremiumTSUSF vs JP:3148Unlock the JP:3148 top-analyst price target with TipRanks Premium
JP:3349COSMOS Pharmaceutical CorporationJPY 6,032.00JPY 480.15B14.88-12.39%―Unlock the JP:3349 analyst price target with TipRanks PremiumTSUSF vs JP:3349Unlock the JP:3349 top-analyst price target with TipRanks Premium
JP:3549KUSURI NO AOKI HOLDINGS CO.,LTD.JPY 4,373.00JPY 418.12B21.9414.03%―Unlock the JP:3549 analyst price target with TipRanks PremiumTSUSF vs JP:3549Unlock the JP:3549 top-analyst price target with TipRanks Premium

Performance Comparison

-30%-20%-10%0%10%20%30%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
TSUSFTSURUHA Holdings14.12-3.13-18.14%
JP:9989Sundrug Co3616.00-399.89-9.96%
JP:7649Sugi Holdings Co1304.50-340.92-20.72%
JP:3148Create SD Holdings Co., Ltd.3170.0061.901.99%
JP:3349COSMOS Pharmaceutical Corporation6032.00-789.24-11.57%
JP:3549KUSURI NO AOKI HOLDINGS CO.,LTD.4373.00523.5413.60%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts